GPT and metabolic dysfunction-associated steatotic liver disease: Our investigation revealed that an AAR below 1 was linked to heightened risks associated with both high blood pressure and nonalcoholic fatty liver disease development—potentially influenced by aberrant hepatic function dynamics alongside inflammatory responses or metabolic statuses impacting the balance between AST and ALT ratios—a finding congruent with prior research outcomes [51,52].